| 000 | 01583 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513175216.0 | ||
| 264 | 0 | _c19990429 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0304-3835 | ||
| 024 | 7 |
_a10.1016/s0304-3835(98)00293-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaripagaoglu, M | |
| 245 | 0 | 0 |
_aTreatment results and prognostic factors in inoperable carcinoma of the cervix treated with external plus high dose brachytherapy. _h[electronic resource] |
| 260 |
_bCancer letters _cFeb 1999 |
||
| 300 |
_a17-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBrachytherapy _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xpathology |
| 700 | 1 | _aYalvac, S | |
| 700 | 1 | _aKose, M F | |
| 700 | 1 | _aTulunay, G | |
| 700 | 1 | _aKayikcioglu, F | |
| 700 | 1 | _aCakmak, A | |
| 700 | 1 | _aHaberal, A | |
| 700 | 1 | _aBoran, N | |
| 700 | 1 | _aAdli, M | |
| 700 | 1 | _aHayran, M | |
| 773 | 0 |
_tCancer letters _gvol. 136 _gno. 1 _gp. 17-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0304-3835(98)00293-6 _zAvailable from publisher's website |
| 999 |
_c10171172 _d10171172 |
||